Molecular and biochemical markers in colorectal cancer
- 1 October 2002
- journal article
- review article
- Published by Elsevier in Annals of Oncology
- Vol. 13 (suppl_4) , 235-245
- https://doi.org/10.1093/annonc/mdf665
Abstract
No abstract availableThis publication has 63 references indexed in Scilit:
- Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ studyBritish Journal of Cancer, 2001
- Molecular Predictors of Survival after Adjuvant Chemotherapy for Colon CancerNew England Journal of Medicine, 2001
- Regulation of β-Catenin Signaling in the Wnt PathwayBiochemical and Biophysical Research Communications, 2000
- The p53 Gene in Breast Cancer: Prognostic Value of Complementary DNA Sequencing Versus ImmunohistochemistryJNCI Journal of the National Cancer Institute, 1996
- Quantitation of intratumoral thymidylate synthase expression predicts for resistance to protracted infusion of 5-fluorouracil and weekly leucovorin in disseminated colorectal cancers: Preliminary report from an ongoing trialEuropean Journal Of Cancer, 1995
- A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracilEuropean Journal Of Cancer, 1994
- Mutations of Ki-ras and p53 genes in colorectal cancer and their prognostic significance.Gut, 1994
- Loss of heterozygosity in 8p is associated with microinvasion in colorectal carcinomaGenes, Chromosomes and Cancer, 1994
- Prognostic factors of colorectal cancer: K‐ras mutation, overexpression of the p53 protein, and cell proliferative activityJournal of Surgical Oncology, 1994
- Genetic Alterations during Colorectal-Tumor DevelopmentNew England Journal of Medicine, 1988